Thanks to Hilda Bastian and Scientific American for permission to republish this very timely article that looks back on a Medical Tribunal review sparked by by an HIV AIDS in Sydney in the 1... Read more
Heath Kelly writes: Tuesday’s reports suggesting a particularly severe flu season could easily be overstating the case. The figures, released by Influenza Specialist Group say there have bee... Read more
Most concerns about the Federal Budget’s imposition of a $7 GP co-payment have been around its impact on the health of vulnerable individuals and families. Below Catherine Bateman-Steel and... Read more
By Kellie Bisset What the evidence uncovered Evidence has turned the tables on two issues this past fortnight: whether our multimillion national investment in antiviral drugs is justified; a... Read more
(A Federal Health Department response to this post was added on 18 April). “Most experts would agree that the modest benefits of Tamiflu and Relenza, as reported by the review, do not justif... Read more
Longstanding questions about a key plank of the international response to pandemic influenza - the stockpiling and widespread use of the antiviral drug oseltamivir (Tamiflu) – have bee... Read more
(Following on from the previous post on infection control in hospitals.) The Centre for Research in Critical Infection held a meeting recently at the University of Sydney, where the threat o... Read more